Company: Bluerock Therapeutics
Job title: CIO
Dr Deans is Chief of Innovation at BlueRock Therapeutics, a biotechnology company creating next generation cell therapeutics by harnessing pluripotent stem cell biology and gene editing tools. BlueRock is developing allogeneic cell therapeutics for the blood, brain and heart. Prior to BlueRock, Dr Deans was CSO at Rubius Therapeutics developing a platform of novel enucleated cell therapeutics based on engineering and expansion of hematopoietic progenitors to mature reticulocytes. Dr. Deans has more than 25 years of experience in adult stem cell therapeutics which includes stem cells from bone marrow including both hematopoietic gene therapies as well as mesenchymal stromal cell (MSC) populations.